KK

Kalyani Kodumuri

Active Director Designated Partner DIN 07726166
DIN 07726166 First appointment Feb 2017 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalyani Kodumuri

Data last updated:

Kalyani Kodumuri is a Designated Partner at Filos Biopharma Llp (since 2025). The companies operate in Biotechnology and Pharma. Earlier, Kalyani Kodumuri was a Director at Sortis Pharma Healthcare Private Limited (2017–2024).

DIN 07726166
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 22 Feb 2017
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Jan 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Feb 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Kalyani Kodumuri

NameDINCompanyDesignation
Kodumuri Ankith10916796Filos Biopharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Filos Biopharma Llp
Sortis Pharma Healthcare Private Limited
Premium access

Shareholding and investment profile for Kalyani Kodumuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalyani Kodumuri

Kalyani Kodumuri currently holds 1 directorship: Filos Biopharma Llp (Designated Partner, since 22 Jan 2025).

Kalyani Kodumuri was first appointed on 22 Feb 2017 as Director at Sortis Pharma Healthcare Private Limited. The most recent appointment on record is 22 Jan 2025 at Filos Biopharma Llp.

Kalyani Kodumuri held 1 earlier board appointment: Sortis Pharma Healthcare Private Limited (Director, 22 Feb 2017 to 06 Nov 2024).

The current boards of Kalyani Kodumuri's companies include Kodumuri Ankith (Filos Biopharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available